Christine Eng MD
Clinical Genetics, Clinical Molecular Genetics, Pediatric Medical Genetics
Professor, Molecular & Human Genetics, Baylor College of Medicine
Join to View Full Profile
6701 Fannin StHouston, TX 77030
Phone+1 832-822-4280
Fax+1 832-825-4294
Dr. Eng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount Sinai/Kravis Children'sResidency, Pediatrics, 1986 - 1989
Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterResidency, Pediatrics, 1983 - 1986
Tulane University School of MedicineClass of 1983
Certifications & Licensure
TX State Medical License 2001 - 2026
NY State Medical License 1986 - 2020
LA State Medical License 1983 - 1984
American Board of Pediatrics Pediatrics
American Board of Medical Genetics and Genomics Clinical Molecular Genetics and Genomics
Clinical Trials
- Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase Start of enrollment: 2004 Sep 13
Publications & Presentations
PubMed
- Anaplastic meningioma in a 6-year-old with somatic YAP1::MAML2 fusion and multiple endocrine neoplasia type 4 (MEN4) syndrome.Lauren R Desrosiers-Battu, John H Lee, Izabela Tarasiewicz, Andrea R Gilbert, Eva M Galvan
Cancer Genetics. 2025-04-01 - Experiences from dual genome next-generation sequencing panel testing for mitochondrial disorders: a comprehensive molecular diagnosis.Elizabeth Gorman, Hongzheng Dai, Yanming Feng, William James Craigen, David C Y Chen
Frontiers in Genetics. 2025-01-01 - 2 citationsComparing the Diagnostic Yield of Germline Exome Versus Panel Sequencing in the Diverse Population of the Texas KidsCanSeq Pediatric Cancer Study.Lauren R Desrosiers-Battu, Tao Wang, Jacquelyn Reuther, George Miles, Hongzheng Dai
JCO Precision Oncology. 2024-09-01
Journal Articles
- Publisher Correction: Non-Invasive Prenatal Sequencing for Multiple Mendelian Monogenic Disorders Using Circulating Cell-Free Fetal DNAYue Wang, Arthur Beaudet, Christine M Eng, Ronald J Wapner, Sheetal Parmar, Nature
- Clinical Exome Sequencing for Fetuses with Ultrasound Abnormalities and a Suspected Mendelian DisorderChristine Eng, MD, BioMed Central
- Clinical Exome Sequencing Reveals Locus Heterogeneity and Phenotypic Variability of CohesinopathiesScott E Hickey, Leah Slattery, James R Lupski, Margaret P Adam, Olivia Wenger, Davut Pehlivan, Laura Martin, Farida Abid, Dorothy Grange, Jennifer E Posey, Alison A Be..., Nature
Press Mentions
Ending the Diagnostic Odyssey for PatientsDecember 11th, 2024- How Whole Genome Sequencing Can Lead to Early Diagnosis and InterventionDecember 2nd, 2024
- Diagnostic Laboratory Joint Venture Expands RNA Sequencing at BaylorAugust 6th, 2024
- Join now to see all
Grant Support
- Clinical Trial: A Multicenter Open-Label Study Of Gene-Activated Human GlucocereNational Center For Research Resources2009
- Clinical Trial: An Open-Label Extension Of Study Tkt024 Evaluating Long-Term SAFNational Center For Research Resources2008
- Clinical Trial: A Randomized, Open-Label, Study To Assess The Safety And TolerabNational Center For Research Resources2008
- Expanded Access Use Of Recombinant Human Acid Alpha-Glucosidase (RHGAA) (MyozNational Center For Research Resources2006–2007
- An Open-Label Extension Of Study Tkt024 Evaluating Long-Term Safety And CliniNational Center For Research Resources2006–2007
- Multi-Center, OPEN Label Study Of The Safety And Efficacy Of Fabrazyme In PTSNational Center For Research Resources2006
- Iduronate-2-Sulfatase Enzyme Replacement Therapy In Patients With MPS IINational Center For Research Resources2005–2006
- Study Of The Safety And Efficacy Of Fabrazyme In Fabry PatientsNational Center For Research Resources2005
- Phase 2, Randomized, Open-Label, Dose Ranging, Multiple Dose Study Of Fabrazyme2National Center For Research Resources2004
- Iduronate-2-Sulfatase Enzyme Replacement Therapy In MPSNational Center For Research Resources2004
- Outcomes Of Genetic Testing Among Ashkenazi FamiliesNational Cancer Institute2001–2002
- Safety &Efficacy Of Recombinant Alpha Galactosidase-ANational Center For Research Resources2000–2002
- Recombinant Enzyme Therapy For Fabry'S DiseaseNational Center For Research Resources2000–2002
- Enzyme Replacement Therapy For Fabry DiseaseNational Center For Research Resources1999
- Genetic Testing In Ashkenazi Jewish PopulationNational Center For Research Resources1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
